Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mirum Pharmaceuticals (MIRM) Free Cash Flow: 2020-2025

Historic Free Cash Flow for Mirum Pharmaceuticals (MIRM) over the last 6 years, with Sep 2025 value amounting to $39.5 million.

  • Mirum Pharmaceuticals' Free Cash Flow rose 938.50% to $39.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $44.3 million, marking a year-over-year increase of 2116.29%. This contributed to the annual value of $9.3 million for FY2024, which is 113.13% up from last year.
  • As of Q3 2025, Mirum Pharmaceuticals' Free Cash Flow stood at $39.5 million, which was up 231.49% from $11.9 million recorded in Q2 2025.
  • Over the past 5 years, Mirum Pharmaceuticals' Free Cash Flow peaked at $39.5 million during Q3 2025, and registered a low of -$40.2 million during Q2 2021.
  • Its 3-year average for Free Cash Flow is -$1.1 million, with a median of -$4.6 million in 2024.
  • In the last 5 years, Mirum Pharmaceuticals' Free Cash Flow plummeted by 135.81% in 2021 and then spiked by 938.50% in 2025.
  • Quarterly analysis of 5 years shows Mirum Pharmaceuticals' Free Cash Flow stood at -$33.1 million in 2021, then decreased by 4.11% to -$34.5 million in 2022, then surged by 51.85% to -$16.6 million in 2023, then surged by 69.38% to -$5.1 million in 2024, then surged by 938.50% to $39.5 million in 2025.
  • Its Free Cash Flow stands at $39.5 million for Q3 2025, versus $11.9 million for Q2 2025 and -$2.0 million for Q1 2025.